Venkatesh, D.* ; O'Brien, N.A.* ; Zandkarimi, F.* ; Tong, D.R.* ; Stokes, M.E.* ; Dunn, D.E.* ; Kengmana, E.S.* ; Aron, A.T.* ; Klein, A.M.* ; Csuka, J.M.* ; Moon, S.H.* ; Conrad, M. ; Chang, C.J.* ; Lo, D.C.* ; D'Alessandro, A.* ; Prives, C.* ; Stockwell, B.R.*
     
 
    
        
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling.
    
    
        
    
    
        
        Genes Dev. 34, 526-543 (2020)
    
    
    
		
		
			
				MDM2 and MDMX, negative regulators of the tumor suppressor p53, can work separately and as a heteromeric complex to restrain p53's functions. MDM2 also has pro-oncogenic roles in cells, tissues, and animals that are independent of p53. There is less information available about p53-independent roles of MDMX or the MDM2-MDMX complex. We found that MDM2 and MDMX facilitate ferroptosis in cells with or without p53. Using small molecules, RNA interference reagents, and mutant forms of MDMX, we found that MDM2 and MDMX, likely working in part as a complex, normally facilitate ferroptotic death. We observed that MDM2 and MDMX alter the lipid profile of cells to favor ferroptosis. Inhibition of MDM2 or MDMX leads to increased levels of FSP1 protein and a consequent increase in the levels of coenzyme Q(10), an endogenous lipophilic antioxidant. This suggests that MDM2 and MDMX normally prevent cells from mounting an adequate defense against lipid peroxidation and thereby promote ferroptosis. Moreover, we found that PPAR alpha activity is essential for MDM2 and MDMX to promote ferroptosis, suggesting that the MDM2-MDMX complex regulates lipids through altering PPAR alpha activity. These findings reveal the complexity of cellular responses to MDM2 and MDMX and suggest that MDM2-MDMX inhibition might be useful for preventing degenerative diseases involving ferroptosis. Furthermore, they suggest that MDM2/MDMX amplification may predict sensitivity of some cancers to ferroptosis inducers.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Ferroptosis ; Mdm2 ; Mdmx ; P53-independent ; Ppar Alpha ; Lipid Metabolism ; Fsp1 ; Coq(10) ; Cancer; Proliferator-activated Receptor; Cell-death; P53; Metabolism; Inhibitors; Identification; Oxidation; Apoptosis; Complex; Target
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2020
    
 
    
        Prepublished im Jahr 
        
    
 
    
        HGF-Berichtsjahr
        2020
    
 
    
    
        ISSN (print) / ISBN
        0890-9369
    
 
    
        e-ISSN
        1549-5477
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 34,  
	    Heft: 7-8,  
	    Seiten: 526-543 
	    Artikelnummer: ,  
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            Cold Spring Harbor Laboratory Press
        
 
        
            Verlagsort
            1 Bungtown Rd, Cold Spring Harbor, Ny 11724 Usa
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Forschungsfeld(er)
        Genetics and Epidemiology
    
 
    
        PSP-Element(e)
        G-506900-001
    
 
    
        Förderungen
        
    
 
    
        Copyright
        
    
 	
    
    
    
    
        Erfassungsdatum
        2020-04-20